AFTER more than a decade of constant nausea, mood swings, acne and an expanding waistline, Aida Azizi finally found the ‘cure ...
The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...
FEELING sick and with a pounding headache, Vicki McFarlane knew she had to stop using weight-loss jabs. The 53-year-old, who ...
Everyday Health on MSN
Diabetes: Is the Ozempic pill just as good as the injection?
Learn how the two forms of semaglutide compare in treating type 2 diabetes and supporting weight loss, plus their dosing ...
Daily Mail on MSN
Daily tablet could transform type 2 diabetes treatment, trial finds
Around six million people in the UK are thought to be living with type 2 diabetes, which occurs when the body does not ...
The consensus says that "an accurate new name was prioritised over retaining the PCOS acronym." But the term "PCOS" itself ...
American healthcare has a strange relationship with prevention. We celebrate it rhetorically. We promote it at conferences.
Most patients in the control group received other GLP-1 drugs such as semaglutide, which Novo Nordisk sells for diabetes as ...
Surpass-Early randomized ~800 adults with ≤4-year type 2 diabetes on metformin to add tirzepatide or intensify care, predominantly with semaglutide or dulaglutide comparators. At two years, ...
In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Mary-Elizabeth Patti, MD, and ...
In 2025, Lacavera teamed up with fitness guru and self-proclaimed “life engineer” Gary LeBlanc to launch EverMe, a mobile app ...
ASCO 2026 data show GLP-1 RAs reduce HR+/HER2- breast cancer risk and improve overall survival in non-diabetic women with a BMI of 25-35 kg/m². Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results